Advanced

Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program

McLafferty, Robert B.; Passman, Marc A.; Caprini, Joseph A.; Rooke, Thom W.; Markwell, Steven A.; Lohr, Joanne M.; Meissner, Mark H.; Eklof, Bo G. LU ; Wakefield, Thomas W. and Dalsing, Michael C. (2008) In Journal of Vascular Surgery 48(2). p.394-399
Abstract
Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods. Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29... (More)
Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods. Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease. (Less)
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Journal of Vascular Surgery
volume
48
issue
2
pages
394 - 399
publisher
Mosby
external identifiers
  • wos:000258035800023
  • scopus:47249116467
ISSN
1097-6809
DOI
10.1016/j.jvs.2008.03.041
language
English
LU publication?
yes
id
c80545cc-38b0-4402-95a7-c3741d0e9c07 (old id 1253646)
date added to LUP
2009-07-27 11:57:10
date last changed
2017-11-12 03:35:05
@article{c80545cc-38b0-4402-95a7-c3741d0e9c07,
  abstract     = {Objective: To evaluate the results of the expanded National Venous Screening Program (NVSP) as administered by the American Venous Forum. Methods. Eighty-three physicians across 40 states participated in screening Americans for venous disease. The NVSP instrument included demographics, venous thromboembolism (VTE) risk assessment, quality-of-life (QOL) assessment, duplex ultrasound scan for reflux and obstruction, and clinical inspection. Participants received educational materials and a report card to give their physician. Results: A total of 2234 individuals underwent screening (mean, 26 people/site; range, 4-42). Demographic data observed included mean age of 60 years (range, 17-93 years); 77% female; 80% Caucasian; mean BMI of 29 (range, 11-68); 40% current or previous smoker; and 24% taking antiplatelet therapy and 4% taking warfarin. If placed in a situation conducive for VTE, 40% of participants were low risk, 22% were moderate risk, 21% were high risk, and 17% were very high risk. On a venous QOL assessment, 17% had a combined total score for all 11 questions of "very limited" or "impossible to do." Reflux or obstruction was noted in 37% and 5% of participants, respectively. CEAP class 0 to 6 was 29%, 29%, 23%, 10%, 9%, 1.5%, 0.5%, respectively. Discussion: Despite a dramatic expansion in the second annual NSVP (from 17 to 83 centers), the presence of venous disease observed in a larger screened population continues to be high. The NVSP represents one pathway to increasing public awareness about venous disease.},
  author       = {McLafferty, Robert B. and Passman, Marc A. and Caprini, Joseph A. and Rooke, Thom W. and Markwell, Steven A. and Lohr, Joanne M. and Meissner, Mark H. and Eklof, Bo G. and Wakefield, Thomas W. and Dalsing, Michael C.},
  issn         = {1097-6809},
  language     = {eng},
  number       = {2},
  pages        = {394--399},
  publisher    = {Mosby},
  series       = {Journal of Vascular Surgery},
  title        = {Increasing awareness about venous disease: The American Venous Forum expands the National Venous Screening Program},
  url          = {http://dx.doi.org/10.1016/j.jvs.2008.03.041},
  volume       = {48},
  year         = {2008},
}